A Study of SHR-A2102 in Combination With Adebrelimab and SHR-8068 in Subjects With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
Clinical trial NCT06589778 · RECRUITING
Trial details
- NCT number
- NCT06589778
- Sponsor
- Shanghai Hengrui Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-27
- Primary completion
- 2026-04-30
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.